Another calcium paradox in heart failure

J Mol Cell Cardiol. 2008 Jul;45(1):28-31. doi: 10.1016/j.yjmcc.2008.04.001. Epub 2008 Apr 16.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acetanilides / pharmacology*
  • Acetanilides / therapeutic use
  • Adult
  • Aged
  • Animals
  • Calcium / metabolism*
  • Cardiotonic Agents / pharmacology
  • Cnidarian Venoms / pharmacology
  • Diastole / drug effects
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Heart Failure / drug therapy
  • Heart Failure / metabolism*
  • Heart Failure / pathology
  • Heart Ventricles / metabolism
  • Heart Ventricles / pathology
  • Humans
  • Ion Transport / drug effects
  • Male
  • Middle Aged
  • Myocardial Contraction / drug effects*
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use
  • Rabbits
  • Ranolazine
  • Sodium / metabolism*

Substances

  • Acetanilides
  • Cardiotonic Agents
  • Cnidarian Venoms
  • Enzyme Inhibitors
  • Piperazines
  • toxin II (Anemonia sulcata)
  • Sodium
  • Ranolazine
  • Calcium